Physician

Ronald Walden Milam, M.D.

According to 2025 Medicare claims, Ronald Milam, M.D. (NPI: 1205256724) practices ophthalmology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is CHARLOTTE EYE EAR NOSE & THROAT ASSOCIATES, P.A. (NPI: 1043287469; TIN: 56-1896112) and primary practice location at 28210-3256. Milam is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Milam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,111 traditional Medicare patients, billed 27,971 HCPCS/CPT codes, and received $2,751,312 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 451 prescription claims across 151 beneficiaries totaling $15,624 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 12 records totaling $269. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,894 to $2,751,312. Similarly, Part D prescription costs have risen steadily, from $3,832 to $15,624. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2018 Medicare payment: $6,894 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $14,669 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $149,071 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $728,228 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $765,890 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,266,553 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,751,312 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20185466$6,894
2019114138$14,669
2020190920$149,071
20215134,387$728,228
20226564,511$765,890
202398722,305$2,266,553
20241,11127,971$2,751,312

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.8K$16K2015 Drug cost: $3,832 (USD; Tot_Drug_Cst)2016 Drug cost: $4,075 (USD; Tot_Drug_Cst)2017 Drug cost: $14,385 (USD; Tot_Drug_Cst)2018 Drug cost: $6,960 (USD; Tot_Drug_Cst)2019 Drug cost: $12,063 (USD; Tot_Drug_Cst)2020 Drug cost: $4,078 (USD; Tot_Drug_Cst)2021 Drug cost: $7,320 (USD; Tot_Drug_Cst)2022 Drug cost: $7,611 (USD; Tot_Drug_Cst)2023 Drug cost: $14,587 (USD; Tot_Drug_Cst)2024 Drug cost: $15,624 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152251$3,832
20162444$4,075
20174991$14,385
20184283$6,960
201986206$12,063
202047101$4,078
202173193$7,320
202280197$7,611
2023103318$14,587
2024151451$15,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2152,581$653
67028Injection of drug into eye3671,723$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0252,530$64
J9035Injection, bevacizumab, 10 mg102407$55
92134Imaging of retina1,0072,765$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1485,701$6,872
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat604,542$884
Ciprofloxacin HclCiprofloxacin Hcl771,849$845
Brimonidine TartrateBrimonidine Tartrate20818$793
LatanoprostLatanoprost663,574$455

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$269Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ronald Walden Milam, M.D.?

Tedicare shows public-source Medicare data for Ronald Walden Milam, M.D. (NPI 1205256724), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald Walden Milam, M.D. have ACO affiliation data?

Ronald Walden Milam, M.D. is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Ronald Walden Milam, M.D.?

Ronald Walden Milam, M.D. is linked to CHARLOTTE EYE EAR NOSE & THROAT ASSOCIATES, P.A. (billing NPI 1043287469) in the available physician profile data.

Does Ronald Walden Milam, M.D. have Open Payments data?

Ronald Walden Milam, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.